Open Internet by MindsNet

US Biotech Competitiveness Against Overseas Copycats

The rapid creation of 'me-better' copycat drugs by China threatens the US biotech industry's competitiveness. Companies are becoming more secretive and delaying IP to prevent overseas copycats. The fear is that without government intervention, US biotech cannot compete against China.

Science, Physics, Classical Mechanics